Haemorrhoids and other anal conditions
All NICE products on haemorrhoids and other anal conditions. Includes any guidance and advice.
Search results
18 results for haemorrhoids
-
-
Stapled haemorrhoidopexy for the treatment of haemorrhoids (TA128)
Evidence-based recommendations on stapled haemorrhoidopexy for treating haemorrhoids
-
Radiofrequency treatment for haemorrhoids (IPG589)
Evidence-based recommendations on radiofrequency treatment for haemorrhoids in adults. This involves using radiofrequency energy to shrink the haemorrhoids
-
Superior rectal artery embolisation for haemorrhoids (IPG627)
Evidence-based recommendations on superior rectal artery embolisation for haemorrhoids in adults. This involves blocking the blood vessels supplying the
-
Electrotherapy for the treatment of haemorrhoids (IPG525)
Evidence-based recommendations on electrotherapy for treating grade I to III haemorrhoids in adults. This involves using electric current to shrink the
-
Gastrointestinal conditions
Everything NICE has said on gastrointestinal conditions in an interactive flowchart
-
eXroid for internal haemorrhoids (MIB201)
NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids
-
Haemorrhoidal artery ligation (IPG342)
Evidence-based recommendations on haemorrhoidal artery ligation for treating haemorrhoids (piles)
-
Circular stapled haemorrhoidectomy (IPG34)
Evidence-based recommendations on circular stapled haemorrhoidectomy for treating internal haemorrhoids
-
Further research in superior rectal artery embolisation for haemorrhoids should report details of patient selection, and follow-up efficacy (including symptom relief), need for subsequent treatments, quality of life and safety outcomes for at least 1 year.
Question Further research in superior rectal artery embolisation for haemorrhoids should report details of patient selection, and...
-
NICE encourages further research into radiofrequency treatment for haemorrhoids, preferably randomised controlled trials. It may update the guidance on publication of further evidence. Outcomes should include pain, secondary haemorrhage, recurrence rate, the need for repeat procedures and quality-of-life measures. Details of patient selection should also be reported.
NICE encourages further research into radiofrequency treatment for haemorrhoids, preferably randomised controlled trials. It may update...
-
Faecal incontinence in adults: management (CG49)
This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis.
-
Antenatal care for uncomplicated pregnancies (CG62)
This guideline covers the care that healthy women and their babies should be offered during pregnancy. It aims to ensure that pregnant women are offered regular check-ups, information and support.
-
Postnatal care up to 8 weeks after birth (CG37)
This guideline covers the routine postnatal care women and their babies should receive for 6–8 weeks after the birth. It includes advice given on breastfeeding, and the management of common and serious health problems in women and their babies after the birth.
-
Technology appraisal guidance static list
NICE technology appraisal guidance static list